Literature DB >> 14694524

Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.

Kazuo Kinoshita1, Seiichi Hirota, Koji Isozaki, Akiko Ohashi, Toshirou Nishida, Yukihiko Kitamura, Yasuhisa Shinomura, Yuji Matsuzawa.   

Abstract

Most sporadic gastrointestinal stromal tumours (GISTs) have somatic c-kit gene mutations that are considered to be causal. Neurofibromatosis type 1 (NF1) is caused by mutations of the NF1 gene and NF1 patients have an increased risk of developing GISTs. Since most neoplasms are considered to develop as a result of the combination of several gene mutations, these findings suggest that GISTs from NF1 patients might have somatic c-kit gene mutations and that sporadic GISTs from non-NF1 patients might have somatic NF1 gene mutations. The present study analysed 29 GISTs from seven NF1 patients for c-kit gene mutations and ten sporadic GISTs from ten non-NF1 patients for NF1 mutations. Exons 9, 11, 13, and 17 of the c-kit gene were amplified and directly sequenced after the extraction of genomic DNA from wax-embedded tissues from 26 GISTs from five NF1 patients. The whole coding region of the c-kit cDNA and the whole coding region of the NF1 cDNA were amplified and directly sequenced after RNA extraction and cDNA synthesis in three fresh GIST tissues from two NF1 patients and ten fresh GIST tissues from ten non-NF1 patients. Of the ten sporadic GISTs, eight had heterozygous mutations at exon 11, and one at exon 9, of c-kit. Heterozygous NF1 gene mutations were detected in GISTs from the two NF1 patients from whom fresh tissues were available. None of the 29 GISTs derived from NF1 patients had detectable c-kit gene mutations and none of the ten GISTs derived from non-NF1 patients had detectable NF1 mutations. These results suggest that the pathogenesis of GISTs in NF1 patients is different from that in non-NF1 patients. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694524     DOI: 10.1002/path.1487

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  44 in total

Review 1.  Gastrointestinal stromal tumors (GISTs): an updated experience.

Authors:  Anastasios Machairas; Eva Karamitopoulou; Dimitrios Tsapralis; Theodore Karatzas; Nickolas Machairas; Evangelos P Misiakos
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  Greater omentum gastrointestinal stromal tumor with PDGFRA-mutation and hemoperitoneum.

Authors:  Yoko Murayama; Masayuki Yamamoto; Ryuichiro Iwasaki; Tamana Miyazaki; Yukiko Saji; Yoshinori Doi; Haruki Fukuda; Seiichi Hirota; Masahiro Hiratsuka
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

Review 3.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

4.  Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.

Authors:  Jae-Lyun Lee; Jin Young Kim; Min-Hee Ryu; Hye Jin Kang; Heung Moon Chang; Tae-Won Kim; Hyoungnam Lee; Ji Hyun Park; Hee Cheol Kim; Jung Sun Kim; Yoon-Koo Kang
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

Review 5.  GISTogram: a graphic presentation of the growing GIST complexity.

Authors:  Riccardo Ricci; Angelo Paolo Dei Tos; Guido Rindi
Journal:  Virchows Arch       Date:  2013-08-23       Impact factor: 4.064

Review 6.  An update on molecular genetics of gastrointestinal stromal tumours.

Authors:  L Tornillo; L M Terracciano
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

7.  A gastrointestinal stromal tumor in a patient with multiple endocrine neoplasia type 2A and metastatic medullary thyroid cancer to the ovaries.

Authors:  Rana Malek; Desiree McCarthy-Keith; Eric D Levens; Maria J Merino; Alan H DeCherney; Lee S Weinstein
Journal:  Endocr Pract       Date:  2008-10       Impact factor: 3.443

Review 8.  Genetic aberrations of gastrointestinal stromal tumors.

Authors:  Jilong Yang; Xiaoling Du; Alexander J F Lazar; Raphael Pollock; Kelly Hunt; Kexin Chen; Xishan Hao; Jonathan Trent; Wei Zhang
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

9.  Multiple gastrointestinal stromal tumors in neurofibromatosis type 1: report of a case.

Authors:  Kotaro Hirashima; Hiroshi Takamori; Masahiko Hirota; Hiroshi Tanaka; Atsushi Ichihara; Yasuo Sakamoto; Yoshiaki Ikuta; Ryu-ichi Karashima; Masayuki Watanabe; Ken-ichi Iyama; Hideo Baba
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

10.  Long segmental hyperplasia of interstitial cells of Cajal with giant diverticulum formation.

Authors:  Liyan Xue; Tian Qiu; Ying Song; Ling Shan; Xiuyun Liu; Lei Guo; Jianming Ying; Shuangmei Zou; Susheng Shi; Alexandros D Polydorides; Xinming Zhao; Ning Lu; Dongmei Lin
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.